Marketing Authorisation for Gliolan® granted in Jordan

13th March 2025

photonamic GmbH & Co KG (Photonamic) are pleased to announce the approval of Gliolan® (5-ALA) in Jordan, marking a significant milestone as the first marketing authorisation for this product in the Middle East Region. This achievement has been made possible through our collaboration with Al Hilal Drug Store, one of the long-established pharmaceutical trading companies in Jordan since 1978.

Read Full Press Release

photonamic GmbH & Co. KG

Eggerstedter Weg 12
25421 Pinneberg
Germany

Enquiry Form

Enquiry Form

If you are interested in 5-ALA and want to collaborate or partner with us, please get in touch.

Privacy Overview
photonamic

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.